Robotized Navigation Compared to Conventional Technique in Total Knee Replacement (NavioRCT)

March 12, 2025 updated by: Haukeland University Hospital

Robotized Computer Navigation Versus Conventional Technique in Total Knee Replacement. a Randomized, Clinical and Radiostereometric Trial.

Navio is a new generation of computer navigation systems allowing intraoperative navigation of the bone cuts relative to both ligaments and skeletal axes, prior to bone removal. An improved accuracy is incorporated by the use of robotics in a burr for bone removal.

This study investigates whether this advanced technology leads to better clinical or radiostereometric results, by comparing one group operated with Navio to another group operated with conventional technique.

Study Overview

Status

Active, not recruiting

Detailed Description

Background:

The scientific foundation of total knee replacement (TKR) surgery is incomplete. As a national governor of joint replacements, the Norwegian Arthroplasty Register is obligated to strict regulations, demanding high levels of evidence for implants and instruments utilized by Norwegian surgeons. It is well known that 15-20% of patients with a TKR, are dissatisfied. Nevertheless, only a small proportion of these patients have revision surgery.

In this randomized, clinical trial we will use the Journey II BCS total knee system, with a more native anatomical design, intended to improve the kinematics and functional outcomes by mimicking a native knee, with respect to geometry and its interplay with the ligaments and soft tissue envelope of the knee (i.e. the biomechanics; stability, joint line, off-set, sizing etc.). To achieve an optimal placement of the implant, the surgeon needs to assess a lot of information (experience) during the surgical procedure. To secure this process, and to make sure all aspects are taken into account, with respect to an optimal positioning and ligament balancing, the computer navigation technique may offer valuable input, with further enhancement of the accuracy and precision using precision tools like the Navio from Smith & Nephew. The Navio system combines robotics and computer navigation, and represents the newest technology within surgical robotics and haptics. This trial is important in the mandatory evaluation process needed, before introducing new technology into orthopaedic surgery, on a larger scale.

Methods:

The surgeons involved have been trained at a wet lab, and on saw bones, before utilizing this tool in a live setting. After the introduction period, the training will continue in a clinical setting until the surgeons have operated at least 20 Navio assisted cases each, followed by a pilot study of 10 patients. All patients will be randomized to either Navio or Conventional technique.

Surgical method: A tourniquet is used. All implant components are cemented (Palacos R+G bone cement is utilized 10 minutes after retrieval from a 4 degrees Celsius refrigerator). Standard para-patellar approach. ACL and PCL are removed. Closing of the wound and capsule in mid-flexion position, Quill for the capsule, Vicryl for the subcutaneous tissue, continuous overlapping mattress with Ethilon suture for the skin. No drainage. Wrapping of the entire limb with elastic dressings for the first 48 hours. Prophylactic antibiotics and anticoagulants are given. Tranexamic acid to reduce bleeding. Postop pain medication: gabapentin, acetaminophen, naproxen, femoral triangle nerve block (repeated next day if needed).

For the conventional group: The rotational alignment is set according to Whiteside's line, and intramedullary rods with 5, 6 or 7 degrees valgus, are selected for the distal femoral cut (dependent on pre-operatively measured angles on long radiographs (hip-knee-ankle). The entry hole of the rod is plugged with bone from the femur to reduce bleeding from the intramedullary canal. The tibial component (metal) is positioned with a 3 degrees posterior slope.

For the Navio group: The cuts are navigated to optimize ligament balance in flexion and extension, and adjusted for mid-flexion instability when needed. A difference of less than 4 mm between lateral and medial gaps is accepted when the laxity is on the lateral side, preferably in flexion. However, if the gap balancing technique suggests a deviation from mechanical alignment of more than 2 degrees of valgus or 4 degrees of varus, the suggestion is overruled by the mechanical alignment (maximum 2 degrees valgus, less than 4 degrees varus).

Sample size calculations: To detect a clinically important difference of 0.17 in the rate of "high responders" and "non-responders" (OMERACT-OARSI criteria) to the Navio, with a standard deviation of 20, power 80% and a 0.05 significance level, a total of 194 patients must be included in the trial (97 patients in each group). The calculations are based on data from a previous study, by Petursson et al, JBJS Am 2018. When 10% eventual drop-outs are taken into account, the total number of patients to be included is 214 (107 patients in each group).

A large number of patients is important, as the expected difference between the groups is small. A small difference may be less clinically relevant, however, may contribute to an overall better outcome for the patients in total. A small improvement of the tools combined with other small improvements may add up to be clinically important in the end. Small trials with no significant differences may disqualify important small improvements, thus stopping any further development in the field. Consequently, large clinical trials will be valuable.

A radiostereometric analysis constitutes a separate study of the trial. A clinically relevant difference of 0.1 mm between the groups will be detected with a standard deviation of 0.1, power 80% and significance level 0.05, if 17 patients are included in each group. Including eventual drop-outs and an expectation of some failures due to the technically challenging investigation method (the RSA), a total of 30 patients will be included in each group. RSA radiographs will be collected within the first week after the operation, at 3 months, 1 year, 2 years and 5 years follow-ups.

The trial is approved by the regional ethics committee and the data inspectorate of Norway.

Study Type

Interventional

Enrollment (Estimated)

214

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bergen, Norway, 5021
        • Haukeland University Hospital
      • Haugesund, Norway, 5504
        • Haugesund sanitetsforenings revmatismesykehus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Degenerative knee in need of a total knee arthroplasty
  • Recruited from the hospital's waiting list
  • Informed consent

Exclusion Criteria:

  • Severe systemic illness
  • Infections
  • Severe neurological dysfunction
  • Severe cancer disease
  • Severe incompensated heart failure
  • Severe incompensated lung disease
  • Dementia
  • Previous fracture or deformity of the limb, making the use of an intramedullary rod impossible (same side hip or ankle implant is not to be excluded if the rod unaffectedly reaches more than the first half of the femoral canal)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Navio
Using the new technology during surgery
New generation computer navigation with haptics and robotics
Active Comparator: Conventional
Using the conventional surgical instruments
Total knee arthroplasty using conventional instruments

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) high responders
Time Frame: 3 months
Difference in rate (0.00-1.00) of high responders (calculated from KOOS)
3 months
WOMAC high responders
Time Frame: 1 year
Difference in rate (0.00-1.00) of high responders (calculated from KOOS)
1 year
WOMAC high responders
Time Frame: 2 years
Difference in rate (0.00-1.00) of high responders (calculated from KOOS)
2 years
WOMAC high responders
Time Frame: 5 years
Difference in rate (0.00-1.00) of high responders (calculated from KOOS)
5 years
Radiostereometric migration
Time Frame: 1 year
Maximum total point of motion MTPM (millimeters), (includes only first 60 patients)
1 year
Radiostereometric migration
Time Frame: 2 years
Maximum total point of motion MTPM (millimeters), (includes only first 60 patients)
2 years
Radiostereometric migration
Time Frame: 5 years
Maximum total point of motion MTPM (millimeters), (includes only first 60 patients)
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee injury and osteoarthritis outcome score (KOOS)
Time Frame: 3 months
Symptoms, Stiffness, Pain, Activity of daily living, Sports, Quality of life subscores (0(worse)-100(better))
3 months
Knee injury and osteoarthritis outcome score (KOOS)
Time Frame: 1 year
Symptoms, Stiffness, Pain, Activity of daily living, Sports, Quality of life subscores (0-100)
1 year
Knee injury and osteoarthritis outcome score (KOOS)
Time Frame: 2 years
Symptoms, Stiffness, Pain, Activity of daily living, Sports, Quality of life subscores (0-100)
2 years
Knee injury and osteoarthritis outcome score (KOOS)
Time Frame: 5 years
Symptoms, Stiffness, Pain, Activity of daily living, Sports, Quality of life subscores (0-100)
5 years
Knee society score (KSS)
Time Frame: 3 months
Knee society score, knee score (0(worse)-100(better)) and function score (0(worse)-100(better))
3 months
Knee society score (KSS)
Time Frame: 1 year
Knee society score, knee score (0-100) and function score (0-100)
1 year
Knee society score (KSS)
Time Frame: 2 years
Knee society score, knee score (0-100) and function score (0-100)
2 years
Knee society score (KSS)
Time Frame: 5 years
Knee society score, knee score (0-100) and function score (0-100)
5 years
EQ-5D
Time Frame: 3 months
Euroqol, quality of life (0(worse)-100(better))
3 months
EQ-5D
Time Frame: 1 year
Euroqol, quality of life (0-100)
1 year
EQ-5D
Time Frame: 2 years
Euroqol, quality of life (0-100)
2 years
EQ-5D
Time Frame: 5 years
Euroqol, quality of life (0-100)
5 years
Visual analogue scale (VAS)
Time Frame: pre-op, 3 months, 1 year, 2 years, 5 years
Visual Analogue Scale pain (0(worse)-100(better))
pre-op, 3 months, 1 year, 2 years, 5 years
Forgotten Joint Score (FJS)
Time Frame: 3 months
Forgotten Joint Score (0(worse)-100(better))
3 months
Forgotten Joint Score (FJS)
Time Frame: 1 year
Forgotten Joint Score (0-100)
1 year
Forgotten Joint Score (FJS)
Time Frame: 2 years
Forgotten Joint Score (0-100)
2 years
Forgotten Joint Score (FJS)
Time Frame: 5 years
Forgotten Joint Score (0-100)
5 years
Maximum climb-up test
Time Frame: 3 months
Height (cm) of one stair climbed with affected/operated limb (no pulling by hands)
3 months
Maximum climb-up test
Time Frame: 1 year
Height (cm) of one stair climbed with affected/operated limb (no pulling by hands)
1 year
Anchor questions
Time Frame: 2 years
Are you satisfied with the outcome? Would you do it again?
2 years
Anchor questions
Time Frame: 5 years
Are you satisfied with the outcome? Would you do it again?
5 years
Timed 40 meters walking test
Time Frame: 3 months
Time spent walking 40 meters
3 months
Timed 40 meters walking test
Time Frame: 1 year
Time spent (in seconds) walking 40 meters
1 year
Chair test 30 seconds
Time Frame: 3 months
number of repetitions from sitting to standing position during 30 seconds
3 months
Chair test 30 seconds
Time Frame: 1 year
number of repetitions from sitting to standing position during 30 seconds
1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Position of the implant on radiographs, coronal and sagittal plane
Time Frame: 3 months
Femoral/tibial components: varus/valgus and flexion/extension, off-set of the femoral component
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ove Furnes, MD/PhD, University of Bergen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 7, 2020

Primary Completion (Actual)

May 1, 2023

Study Completion (Estimated)

December 31, 2031

Study Registration Dates

First Submitted

August 17, 2020

First Submitted That Met QC Criteria

August 21, 2020

First Posted (Actual)

August 25, 2020

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 12, 2025

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2020/68448

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteo Arthritis Knee

Clinical Trials on Navio

Subscribe